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Abstract
A degradable, antimicrobial polymer network with acetal crosslink junctions
derived from p-anisaldehyde (pA), a common constituent found in star anise extract, is
reported. The p-anisaldehyde was converted into a bis-functional acetal alkene monomer,
which serves as a pro-antimicrobial form of the active aldehyde and a building block for
materials referred to as pro-antimicrobial polymer networks via degradable acetals
(PANDAs).

Subsequently,

the

bis-functional

acetal

alkene

monomer

was

photopolymerized with a multifunctional thiol to yield a thiol-ene network. PANDAs
exhibit surface erosion behavior and yield sustained release of pA over 38 days when
exposed to neutral or biologically relevant conditions. The pA released from PANDAs was
shown to be effective against bacterial pathogens, including Escherichia coli,
Staphylococcus aureus, Salmonella enterica serovar Typhi, and Pseudomonas aeruginosa.
The result from this thesis points to promising routes for the design of completely
degradable antimicrobial systems exhibiting sustained-release profiles with potential
applications in pharmaceuticals, cosmetics, food packaging, and agriculture industries.
Keywords: thiol-ene, pro-antimicrobial, sustained-release, essential oils
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Chapter I: Introduction
Antimicrobial resistance is an escalating crisis that threatens the sustainability of
public health and agricultural ecosystems – a crisis that serves as the source of 700,000
deaths around the world on an annual basis.1 As antibiotic effectiveness declines
precipitously, a growing awareness of natural, plant-derived antimicrobial constituents has
proliferated. Essential oils (EOs) are plant extracts that contain antimicrobial terpenes,
aldehydes, and terpenoids. EOs have emerged as an effective alternative to antibiotics in
fighting pathogenic microorganisms.2-3 However, EOs exhibit low water solubility, high
volatility, and are often chemically unstable; these challenges make practical applications
of EOs difficult. Many strategies have been reported for encapsulation of EOs within films
and colloidal systems;4-5 however, deficiencies in these strategies are often observed,
including low EO loading, poor EO encapsulation efficiencies, requirements for organic
processing solvents, and uncontrolled release profiles.6
The work described in this thesis project involves the synthesis of new acetal
containing monomers derived from intrinsically antimicrobial benzaldehydes, such as pchlorobenzaldehyde, which have been previously studied by members of the Patton
research group.7 This project, however, focuses specifically on the synthesis and
incorporation of p-anisaldehyde acetal monomer within a pro-antimicrobial thiol-ene
network. Pro-antimicrobial networks, in this case, refer to polymeric networks that undergo
degradation in neutral or mild acidic conditions and release active antimicrobial aldehydes.
Photopolymerization kinetics, degradation and release kinetics, and the antimicrobial
efficacy of both the monomer and corresponding networks were investigated.
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Chapter II: Literature Review
2.1 Antibiotic Resistance
From the discovery of penicillin in 1928, to some of the most advanced medical
discoveries of the 20th century, our society has heavily relied on the development of new
antimicrobial compounds to remedy infections. However, pathogenic microbes are
continually evolving, rendering the medicines used to treat infections caused by these
pathogens ineffective. Over the last few years, the number of antibiotic discoveries has
declined and simultaneously there has been an over-prescription of existing antibiotics.
From 2000-2010 there has been a 40% increase of antibiotics globally in hospitals.1 This
overuse partially stems from the fact that many areas have access to over the counter and
without prescription antibiotics; further, there has been an increase in counterfeit and substandard antibiotics on the market in various regions.1
Patients infected by drug resistant strains of bacteria suffer from a higher death rate,
and a larger hospital bill. Methicillin-resistant strains of bacteria refer to any bacteria
resistant to both penicillin and cephalosporin drug classes. In Europe, greater than 10% of
staphylococcus aureus infections stem from methicillin-resistant staphylococcus aureus
(MRSA).1 Similarly, foodborne illnesses are also a problem. Around 30% of the population
in industrialized countries will contract a food borne illness each year, some of which are
caused by antibiotic resistant strains of bacteria; two million people died from a diarrheal
disease in the year 2000.2 Poorer communities suffer from drug resistant tuberculosis (TB),
of which 480,000 new cases of resistant TB were reported in 2013; malaria, and Human
Immunodeficiency Virus (HIV) that eventually causes the disease AIDS, also affect a large
number of these populations.1 Immunosuppressed patients, such as those infected with
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HIV, or people who have recently undergone organ or bone marrow transplants, are more
likely to contract bacterial infections.8 Pathogen transmission is an issue, especially with
bacteria, as they share genetic information, creating new drug resistant forms of
themselves. International travel allows these pathogens to travel worldwide, thus creating
a global crises. Studies by O’Neil have projected that, if left untreated, by 2050, 10 million
people would die globally due to drug resistance.1 Further, 10 trillion USD will be spent
yearly to tackle infections arising from these “superbugs”. Undoubtedly, these untreatable
infections will result in global suffering if actions are not implemented to effectively
mitigate the spread of antibiotic-resistant pathogens.1
2.2 Essential Oils as Antimicrobials
As our strongest antibiotics lose efficacy, scientists have turned to nature as an
alternative source for antimicrobial compounds. Essential oils (EOs), or extracts derived
from plants, have been used throughout history to combat a variety of infections. The
desired effect of these EOs is directly related to the functional groups present within the
constituents of the oil. Different functionalities such as alcohols, aldehydes, esters, ketones
and phenols present in the constituents linalool (flowers), citronellal (citrus), carvone
(spearmint/dill), and carvacrol (oregano), respectively, give rise to various antimicrobial
effects.9 Current research has shown that EOs also exhibit antiviral, antimycotic,
antitoxigenic, antiparasitic, and insecticidal properties.2 The antimicrobial properties of
EOs can be attributed to a variety of mechanisms. For example, the hydrophobic nature of
EOs enables them to partition within the lipids of the bacterial cell membrane rendering
the membrane more permeable.2 The increased permeation leads to leakage of the contents
from the cell, resulting in cell death. Phenolic EOs such as carvacrol are thought to disrupt
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the proton motive force, electron flow, and active transport, and cause coagulation of the
cell contents, leading to cell death.2
Inouye and coworkers effectively demonstrated the capability of aldehydecontaining constituents to kill various strains of bacteria. Their study focused on comparing
the effectiveness of different functionalities against gram-positive and gram-negative
bacteria. Phenolics, terpenes, aldehydes, terpene ketones, and esters were examined. The
aldehyde-containing constituents used were citral, octanal, and nonanal (all found in
citrus), cinnamaldehyde (cinnamon), and perillaldehyde (perilla herb). Their results
showed that constituents containing aldehydes or phenols are the most active against
bacteria, and all others were significantly weaker.10
Potential applications include food packaging in which bacteria such as Salmonella,
E. coli, and L. monocytogenes are an issue. EOs have been incorporated directly into foods
or food packaging materials to increase the shelf life of products that are prone to spoilage.
One important requirement within the food packaging industry is that the concentration of
EO must be high enough to exert antimicrobial effects while not altering the flavor of the
food.2
2.3 Encapsulating Essential Oils
Polymer nanoparticles have been utilized in pharmaceutical, biomedical, and
cosmetic industries. These particles have gained attention due to their ability to protect
bioactive compounds, such as EOs or other drugs, from sources that initiate degradation:
light, heat and oxygen. Nanoparticles also act as a carrier, delivering active drugs to their
targets; this allows for better bioavailability of hydrophobic drugs. Similarly, they can
result in a prolonged release within the therapeutic window. Many methods for
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encapsulating EOs within polymeric particles have been reported, such as
nanoprecipitation, coacervation, spray drying, rapid expansion of supercritical solutions,
and most commonly, encapsulation within solid lipid nanoparticles.6 While these strategies
have their benefits, many of them suffer from multiple issues such as poor encapsulation
efficiencies or substandard release profiles. For example, when thymol, carvacrol and
cholesterol were encapsulated within multilamellar vesicles and dried of solvent, a 4.16%
encapsulation efficiency was observed.4 Recently, Gomes et al. encapsulated both eugenol
and trans-cinnamaldehyde within degradable poly(lactic-co-glycolic acid) (PLGA) matrix
particles, and observed an initial burst release followed by a slower rate of release of the
antimicrobial EOs.11 Organic solvents were used during the encapsulation process which
is non-ideal as residual solvent could remain after the particles are formed. Keawchaoon
and coworkers encapsulated carvacrol within chitosan nanoparticles and found that the
release of carvacrol plateaued within 30 days, releasing 23% in phosphate buffer saline at
pH = 7.12-13 The poor release profile suggests that further improvements in encapsulation
efficiency and controlled release kinetics of EOs from matrices are desired.
Acetal functionalized polymer networks have been utilized by multiple research
groups, as acetals readily degrade at biological pH.14 Linear polyacetals, such as those
synthesized by Heller et al. degrade into non-toxic products and that these polymers show
no preferential accumulation in the major organs.15 The Fréchet group demonstrated the
ability to produce protein-loaded microparticles using acetals as cross-linkers.16
Benzaldehyde acetal was chosen as the cross-linker to control the degradation rate of the
polymer by changing the para position on the molecule. In their specific study, it was
shown that p-methoxy substituted benzaldehyde had a half-life of 24 hours at pH 7.4.14
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Recently, we published a paper describing the use of p-chlorobenzaldehyde derived
pro-antimicrobial networks.7 Real-time Fourier transform infrared spectroscopy revealed
that thiol-ene networks achieved over 95% conversion between thiol and alkene
functionalities. Kinetic release studies, such as the one described in this thesis, showed
gradual release of p-chlorobenzaldehyde over 120 hours (>70% released). The
antimicrobial activity of the pro-antimicrobial network was shown to be effective for both
gram-positive (Bacillus subtilis and S. aureus) and gram-negative (E. coli, P. aeruginosa
and Burkholderia cenocepacia) bacteria with killing efficiency over 99.5% within 24
hours. These acetal-based thiol-ene networks represent a new approach to afford high
loading and a controlled release of antimicrobial agent from crosslinked polymeric
networks.
2.4 Research Overview
Building on our previous efforts employing p-chlorobenzaldehyde as the active
building block for pro-antimicrobial networks via degradable acetals (PANDAs), the work
in this thesis shifts focus away from oil derived compounds for network building blocks
towards bio-based aldehydes found in nature to offer a fully degradable antimicrobial
system based on essential oils. Herein, we employed p-anisaldehyde (pA), an extract from
star anise (Pimpinella anisum) seeds, to fabricate a new class of antimicrobial PANDAs
using thiol-ene photopolymerization. The networks that are derived from p-anisaldehyde
completely degrade when exposed to humid or acidic environments, and upon degradation
release the active form of the EO into the surrounding environment. We demonstrate that
incorporation and subsequent release of pA from a PANDA exhibits potent antimicrobial
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activity against a variety of clinically relevant pathogens. The contents of this thesis were
published as a 2018 peer-reviewed journal article in Acta Biomaterialia.17

Chapter III: Materials and Methods
3.1 Materials
The chemicals p-anisaldehyde (pA), trimethylol propane diallyl ether, 2-hydroxy2-methylpropiophenone
(TMSOTf),
bicarbonate,

(Darocur

dichloromethane
diethyl

ether,

1173),

(DCM),

trimethylsilyl

trifluoromethanesulfonate

allyloxytrimethylsilane,

magnesium

sulfate

(MgSO4),

pyridine,

sodium

dextrose,

2,3,5,6-

tetrachloronitrobenzene, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT), hexane, 0.5 M Tris-HCl in H2O, acetonitrile-d3, Aqua Dead Cell Stain™,
LIVE/DEAD BacLight Bacterial Viability Kit staining kit, BacLight RedoxSensor CTC
Vitality Kit and ethyl acetate were acquired from Thermo Fisher Scientific. Pentaerythritol
tetra(3-mercaptopropionate) (PETMP) was provided by Bruno Bock. Difco Agar, yeast
extract, Bacto Tryptone, Mueller Hinton broth and agar, were from Becton, Dickinson and
Company. Ham's F-12 and trypsin-EDTA were obtained from GIBCO. Hemin chloride
(type II), protoporphyrin IX, histidine (free base), proline, 37% formaldehyde in H2O,
dimethyl sulfoxide (DMSO), fluconazole, fetal bovine serum (FBS), Dulbecco's Modified
Eagle's Medium (DMEM) and N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid
(HEPES) was purchased from Sigma Aldrich. All the materials were obtained at the highest
purity available and used without further purification unless otherwise specified.
3.2. Characterization Methods.
A Bruker Ascend 600 MHz (TopSpin 3.5) spectrometer was used to record 1H/13C
NMR spectra with either chloroform-d or acetonitrile-d3. High resolution mass
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spectroscopy (HRMS) was performed with positive electrospray ionization on a Bruker 12
Tesla APEX-Qe FTICR-MS with an Apollo II ion source. Dynamic mechanical analysis
(DMA) was performed using a TA Instruments Q800 dynamic mechanical analyzer in
tension mode equipped with a gas cooling accessory. Samples were clamped, evaluated at
a strain of 1 %, and heated from -80 °C to 80 °C at a ramp rate of 3 °C min-1. Kinetic data
was obtained using real-time FTIR (RT-FTIR) spectroscopy by determining the
conversions of the thiol and ene functional groups. The RT-FTIR studies were conducted
using a Nicolet 8700 FTIR spectrometer with a KBr beam splitter and a MCT/A detector
with a 320–500 nm filtered ultraviolet light source. Each sample was exposed to UV light
with an intensity of 400 mW cm-2. Series scans were recorded, where spectra were taken
approximately 2 scans s-1 with a resolution of 4 cm-1. Thiol conversion was monitored via
integration of the SH peak between 2500-2620 cm-1 while the conversion of the alkene was
monitored between 3050-3125 cm-1. Optical density (OD) and fluorescence readings were
performed in a BioTek Synergy 2 programmable microplate reader (BioTek Instruments).
3.3 Synthesis and Characterization of Monomer
The procedure of Noyori et al..18 was modified to synthesize p-anisaldehyde acetal
(pAA) monomer (Scheme 1). A 250-mL round bottom flask was flame dried and equipped
with a stir bar. Trimethylsilyl trifluoromethanesulfonate (TMSOTf, 200 mL) was added to
the round bottom flask along with 20 mL of dichloromethane (DCM) under a nitrogen
atmosphere at -84°C. Allyloxytrimethylsilane (37 mL, 208 mmol), p-anisaldehyde (pA),
12g, 88 mmol), and 25 mL of DCM were mixed together and added dropwise to the round
bottom; the reaction was stirred for 3 hours, warmed to -30°C and stirred for another hour.
It was quenched with 15 mL of pyridine and then added to 100 mL of sodium bicarbonate
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solution. The quenched reaction mixture was then extracted 3 times with 100 mL of diethyl
ether and dried with MgSO4. The solvent was removed in vacuo and the resulting residue
was purified via column chromatography using a 9:1 hexanes:ethyl acetate solvent mixture
in order to remove any residual aldehyde. Purification yielded a clear oil (13.6 g, 65.9 %
yield). 1H NMR (CDCl3) δ 7.45 (dd), 6.93 (dd), 5.97 (m), 5.62 (s), 5.35 (dd), 5.17 (dd),
4.07 (d), 3.82 (s).
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C NMR (CDCl3) δ 159.66, 134.16, 130.68, 127.97, 116.67, 113.52,

100.29, 66.00, and 55.22. HRMS (ESI+) m/z calculated for C14H18O3 [M+Na]+
257.114816; Found 257.114817.
3.4 Preparation of PANDA Disks
Disks were prepared by combining PETMP, pAA (molar ratio of SH:alkene of 1:1),
and 4 weight % of Darocur 1173 (photoinitiator) in a 20 mL scintillation vial, then mixed
thoroughly. The mixture, in different µL amounts (changed depending on the experiment
the films were used for), were pipetted onto a glass slide, and then covered with another
slide spaced with Teflon spacers. The samples were then cured using an Omnicure S10001B with a 100W mercury lamp (λmax = 365 nm, 320–500 nm filter) at an intensity of 400
mW cm−2 for 30 seconds on each side. Control disks were prepared in the same way, but
with trimethylol propane diallyl ether (non-degradable) instead of pAA.
3.5 Degradation Studies
3.5.1 Optical Degradation
Surface erosion was monitored via optical microscopy. Both a PANDA film and a
control film were prepared as stated above and placed in a 1 N HCl aqueous solution.
Pictures were taken over the course of three hours, with one image per 5 minutes. To graph
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the degradation over time, the remaining disk area, At, was plotted with respect to the initial
area A∞. These results were then fitted to the Hopfenberg model.19
3.5.2 Analysis of Degradation and Release via NMR
The release of pA over time was analyzed via NMR spectroscopy. 2,3,5,6tetrachloronitrobenzene, used as an internal standard, was dissolved into 500 mL of
deuterated acetonitrile. 125 mL of 100 mM Tris-HCl buffer, pH 7.4, was then mixed in;
the resulting solution was added to an NMR tube containing a 5 mL PANDA disk, and
flame sealed. The proton connected to the aldehyde results in a peak around 10 ppm, and
this was integrated with respect to the internal standard to determine the concentration of
pA in solution over a period of 38 days.
3.6 Antimicrobial Assays
3.6.1 Zone of Inhibition
The antimicrobial activity of PANDA disks was tested against several species of
bacteria via the zone of inhibition (ZOI) method. The indicator microorganisms included
Escherichia coli ATCC 43895 (serotype O157:H7), Staphylococcus aureus RN6390,
Salmonella enterica serovar Typhi ATCC 6539 (Sal. Typhi), and Pseudomonas aeruginosa
PAO1. The testing was done on Mueller Hinton II agar (MHA) plates that have been
overlaid with soft agar seeded with individual bacterial strains. The soft agar contained (per
liter): 10 g of Bacto Tryptone, 6 g of Difco agar, and 8 g of sodium chloride. To create an
overlay, the indicator organisms were grown overnight at 37 °C in Mueller Hinton II broth
(MHB). The overnight cultures were diluted 1:5 with fresh MHB, and mixed with molten
soft agar to achieve a ~108 CFU mL−C density. From this mixture, 4 mL aliquots were
overlaid onto MHA base plates and allowed to completely solidify. After solidification of
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the soft agar, 50 mm3 disks were overlaid on the plates and incubated at 37 °C. The zones
of inhibition (ZOI) were measured after 24 h and reported as the distance from the edge of
the disk to the edge of the zone. Three replicates were carried out for each disk/bacterial
strain, with the mean and standard deviation reported (experiment was repeated twice).
3.6.2 Minimum Inhibitory Assay
A modified broth macrodilution method was used to determine the minimum size
of PANDA disks needed to inhibit bacterial growth. Briefly, overnight bacterial cultures
in MHB were adjusted to ~105 CFU mL-1. PANDA disks of different sizes (5-100 mm3)
were added to 4 mL of bacterial cultures. The tubes were then incubated at 37 °C and
shaken at 200 rpm for 24 h. Bacteria suspended in MHB served as a positive control, while
MHB without bacterial inoculum served as a negative control. The inoculated tubes were
assessed by measuring optical density at 600 nm after 24 h, where OD < 0.05 was
considered negative for bacterial growth. Three replicates were carried out for each disk
size and bacterial strain, with the mean and standard deviation reported (experiment
repeated twice).
3.7 Cell Membrane Integrity
3.7.1 LIVE/DEAD Staining
A LIVE/DEAD BacLight Bacterial Viability Kit was used to probe the cell
membrane integrity of the chosen bacteria. P. aeruginosa was diluted to 105 CFU/mL, and
4 mL of this suspension was exposed to a 100 mm3 PANDA film. This was then incubated
at 37°C while shaken at 200 rpm. A 100-mL aliquot was removed at 0 h and 30 h, and
these aliquots were placed into a Corning 96-well solid black microplate and then mixed
with 100 mL of LIVE/DEAD staining agent. They were then incubated, in the dark, for 15
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minutes before the fluorescence was measured with a 528/20 nm excitation filter for the
SYTO9 indicator, a 620/40 nm filter for the propidium iodide indicator, and 485/20 nm
excitation filter for both indicators. Confocal imaging was completed by applying 5 mL of
the stained samples onto microscope slides. The samples were assayed in triplicate and the
experiment was repeated twice.
3.7.2 TEM Imaging
Transmission electron micrographs of the bacterial suspensions prepared as
described in section 3.6.1 were taken with a Zeiss 900 electron microscope operating at 50
kV and outfitted with a Model 785 Erlangshen ES1000 WCCD camera (Gatan). Samples
were applied to 200 mesh copper grids (3.05 mm, 200 lines per inch square mesh, Electron
Microscopy Sciences) coated with Formvar (5% polyvinyl formal resin).

Chapter IV: Results and Discussion
4.1 Synthesis and Characterization of Monomer
Scheme 1A shows the synthetic
scheme for the preparation of pAA,
which was produced with a yield of 66%
after

purification.

The

resulting

monomer was characterized via

1

H

NMR spectroscopy (Figure 1); peak
assignments were in good agreement
with values reported in the literature.18
To

investigate

the

antimicrobial

properties of the pAA and pA monomers,

Scheme 1: Synthesis, photopolymerization, and degradation
scheme.

10 µL of pure pAA and pA were plated on agar and overlaid with Sal. Typhi (Scheme 1A).
12

Following an incubation period of 24 h,
pAA showed no visible zone of inhibition
indicating the acetal form of the monomer
is not an active antimicrobial compound. In
contrast, pA showed a 1 cm zone of
inhibition. These results indicate that pAA
Figure 1: NMR spectra of monomer.

functions as a pro-antimicrobial compound
exhibiting antimicrobial activity only upon
hydrolysis back to the benzaldehyde.
4.2 Photopolymerization and
Characterization of Polymer Films
PANDA films were fabricated via

Figure 2: Conversion between thiol and alkene monomers

radical-mediated step-growth thiol-ene photopolymerization (Scheme 1B) using
pentaerythritol tetrakis(3-mercaptopropionate) (PETMP) and pAA as monomers. PETMP
and pAA were copolymerized using a 1:1 alkene/thiol mole stoichiometry. Upon
polymerization, the composition of the PANDA films is 47 wt.% pAA, which translates to
pA loading of 27 wt.%. The photopolymerization kinetics, when conducted under a
medium pressure UV light (400 mW
cm−2), were rapid and exhibited nearly
quantitative conversion (>95%, Fig. 2) of
both thiol and alkene functional groups in
less
Figure 3. Dynamic mechanical analysis of PANDA films.

than

60

s.

The

step-growth

polymerization mechanism observed for
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radical-mediated thiol-ene polymerization of PETMP and pAA ensures that each crosslink
junction contains a hydrolytically cleavable acetal linkage for the release of pA from the
network (Scheme 1C). Additionally, the resulting PANDAs possess a narrow tan 
(indicative of a homogenous network), a glass transition temperature of -0.5 °C (Fig. 3)
and are optically transparent – typical
of thiol-ene materials.
4.3 Degradation Studies
The PANDA degradation and pA
release

kinetics

characterized

were

using

1

initially
H

NMR

spectroscopy. The kinetic experiment
was conducted over 38 days at pH 7.4
by inserting disks in acetonitriled3/buffer solutions in sealed NMR
tubes. 2,3,5,6-tetrachloronitrobenzene
Figure 4. (A) NMR spectra of degradation products (B)
Release of aldehyde and corresponding fit to Hopfenburg
model.

( = 7.75 ppm) was employed as an
internal standard enabling integration

relative to the benzylic aldehyde proton ( = 9.85 ppm) to determine time-resolved pA
concentration (Fig. 4A). The release profile of pA obtained from the integrated 1H NMR
data is shown in Figure 4B. At pH 7.4, an initial burst release was
not observed; however, a slow release profile was observed
where 90% pA was released within 38 days. To better quantify
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𝑀𝑡
𝑘0 𝑡
=1− 1−
𝑀∞
𝐶0 𝑎

Equation 1: Hopfenberg Model
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the release data, the release profile
was fit to the cylindrical Hopfenberg
model 19 described in Equation 1:
where, 𝑀𝑡 is the concentration of
released pA at time t, 𝑀∞ is the
theoretical maximum of pA released,
𝑘0 is the erosion rate constant, 𝐶0 is
the initial concentration of drug in the
matrix, and a is the initial radius of
the cylinder. The half-life of the

Figure 5. (A) Visual degradation of PANDA films in 1 N HCl (B)
Plotted degradation fit to Hopfenberg model

PANDA degradation was determined to be 14.9 days from the Hopfenberg model. To
investigate the process of erosion for the PANDA disks over time, PANDA disks and nondegradable control disks (trimethylolpropane diallyl ether and PETMP) were fabricated,
submerged in a 1N aqueous HCl solution, and imaged using optical microscopy over time.
The optical images from the accelerated degradation experiment are shown in Figure 5A.
Within 1 h, significant surface erosion was observed. The low solubility of the panisaldehyde and tetrafunctional alcohol (degradation products) in water results in the solid
disk degrading to an oil-like residue within 3 h. The area of the degradation front, as
highlighted by the green arrows in Figure 5A, was used to quantify the degradation process
under low pH conditions. A plot of the remaining disk area at time t (At) relative to the
initial area (A) was plotted over time and then fit to the Hopfenberg model, where 𝑀𝑡 /𝑀∞
were replaced by 𝐴𝑡 /𝐴∞ . The degradation at pH 0.1 was 380x faster (half-life = 0.04 days)
– much faster than expected when compared to the degradation at pH 7.4 observed by
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NMR. The results from these collective degradation studies are consistent with acid
sensitive hydrolysis behavior of acetals.15
4.4 Antimicrobial Assays
4.4.1 Zone of Inhibition
The antimicrobial activity of
both PANDA disks and control disks
was initially evaluated via a ZOI assay
using clinically isolated strains: S.
aureus RN6390 and P. aeruginosa
PAO1, and foodborne pathogens: E.
coli ATCC 43895 (serotype O157:H7)

Figure 6. Zone of inhibition for PANDA and control disks.
Plotted data points represent individual measurements.
data points represent individual measurements. (

and Sal. Typhi ATCC 6539 (Fig. 6). As expected, control disks without p-anisaldehyde
showed no antimicrobial activity for any bacteria in the ZOI experiments. However, ZOIs
greater than 1 cm were observed for the PANDA disks, where larger ZOI values indicate
more potent inhibition of the bacteria.

The ZOI assay showed that the order of

antimicrobial inhibition was Sal. Typhi > S. aureus > E. coli O157:H7 > P. aeruginosa.
4.4.2 Minimum Inhibition Assay
To determine the PANDA disk size required to inhibit bacterial growth, a minimum
inhibitory disk size assay was performed with bacteria in their exponential growth phase
(105 CFU mL-1 in 4 mL media). The bacteria were challenged with PANDA disks (0-100
mm3). Note, larger disk size translates to a higher pA concentration released at a given time
point. The minimum inhibition assay, as presented in Figure 6, showed that inhibition of
bacteria increased with an increase in disk size, and 100 mm3 (910 mg/mL pA) disks
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effectively inhibited all strains of
bacteria tested. An optical density
reading

of

<0.05

is

considered

negative for bacterial growth under
these experimental conditions. E. coli
O157:H7 and P. aeruginosa required
the largest disk size, however, Sal.

Figure 7. Minimum inhibition assay of different sized PANDA
disks.

Typhi and S. aureus were inhibited by 50 mm3 disks (455 mg/mL pA). The concentration
of pA released was estimated from the NMR release profile previously described.
4.5 Cell Membrane Integrity
To investigate the possible mode of action for pA antimicrobial activity, the cell
membrane integrity was analyzed for P.
aeruginosa via a LIVE/DEAD staining – a
method that was supported by TEM imaging.
SYTO9 is capable of penetrating healthy cell
membranes, and results in a green fluorescence;
while propidium iodide only enters cells with
damaged cell membranes resulting in red
fluorescence. Figure 8A shows that at 0h of

Figure 8. LIVE/DEAD staining images (A) at 0h
(B) at 30 h; TEM images (C) at 0h and (D) at
30h

PANDA exposure the P. aeruginosa fluoresced green while after 30 h the sample
fluoresced red, indicating damaged cell membranes. The disruption of the cell membrane
was further concluded with the use of TEM imaging where in Figure 8D there is a clear
disruption of the cell membrane as compared to the healthy bacteria in Figure 8C.
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Chapter V: Conclusion
In this thesis, we have demonstrated a bactericidal, pro-antimicrobial network that
is effective against both gram-positive and gram-negative bacteria. By using confocal
microscopy and TEM imaging, we showed that these antimicrobial polymers mainly kill
bacteria via membrane disruption. Due to the effectiveness of pA and PANDA networks,
these types of polymers could potentially be utilized to combat bacteria in the medical field.
We demonstrated a potent bio-based pro-antimicrobial polymer network that has the
versatility to treat gram positive and gram negative bacterial pathogens through the
sustained release of pA over time. Through a combination of confocal microscopy and
transmission electron microscopy, we showed PANDAs primary mode of action is via
membrane disruption. The design of the PANDA network combined with the potency of
pA has the potential to part of the arsenal of defenses against a broad spectrum of pathogens
and exhibits potential for future in vivo experiments.
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